{
    "elements": [
        {
            "type": "image",
            "sequence_num": 1,
            "data": {
                "url": "16015 Special Requirements Blood Transfusion 2.0.001.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 2,
            "data": {
                "num_rows": 15,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Title:"
                    },
                    {
                        "text": "SPECIAL REQUIREMENTS FOR BLOOD TRANSFUSION"
                    },
                    {
                        "text": "Document Reference/Register no:"
                    },
                    {
                        "text": "16015"
                    },
                    {
                        "text": "Version Number:"
                    },
                    {
                        "text": "2.0"
                    },
                    {
                        "text": "Document type: (Policy/ Guideline/ SOP)"
                    },
                    {
                        "text": "Guideline"
                    },
                    {
                        "text": "To be followed by: (Target Staff)"
                    },
                    {
                        "text": "All Staff"
                    },
                    {
                        "text": "Ratification Issue Date: (Date document is uploaded onto the intranet)"
                    },
                    {
                        "text": "3rd April 2019"
                    },
                    {
                        "text": "Review Date:"
                    },
                    {
                        "text": "2nd April 2022"
                    },
                    {
                        "text": "Developed in response to:"
                    },
                    {
                        "text": "NHSBT & SaBTO guidance for patients with special requirements"
                    },
                    {
                        "text": "Contributes to HSC Act 2008 (Regulated Activities) Regulations 2014(Part 3); and CQC Regulations 2009 (Part 4) CQC Fundamental Standards of Quality and Safety:"
                    },
                    {
                        "text": "12"
                    },
                    {
                        "text": "Issuing Division/Directorate:"
                    },
                    {
                        "text": "Cancer and Support Services"
                    },
                    {
                        "text": "Author/Contact: (Asset Administrator)"
                    },
                    {
                        "text": "Tina Parker, Transfusion Nurse"
                    },
                    {
                        "text": "Hospital Sites: (tick appropriate box/es to indicate status of policy review i.e. joint/ independent)"
                    },
                    {
                        "text": "\uf0fcMEHT \u25a1 BTUH \u25a1 SUH"
                    },
                    {
                        "text": "Consultation:"
                    },
                    {
                        "text": "(Refer to page 2)"
                    },
                    {
                        "text": "Approval Group / Committee(s):"
                    },
                    {
                        "text": "n/a"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "n/a"
                    },
                    {
                        "text": "Professionally Approved by: (Asset Owner)"
                    },
                    {
                        "text": "Dr Shereen Elshazly, Consultant Haematologist"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "4th February 2019"
                    },
                    {
                        "text": "Ratification Group(s):"
                    },
                    {
                        "text": "Document Ratification Group"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "28th March 2019"
                    },
                    {
                        "text": "Executive and Clinical Directors (Communication of minutes from Document Ratification Group"
                    },
                    {
                        "text": "Date: April 2019"
                    },
                    {
                        "text": "Distribution Method:"
                    },
                    {
                        "text": "Intranet & Website"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "image",
            "sequence_num": 3,
            "data": {
                "url": "16015 Special Requirements Blood Transfusion 2.0.002.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 4,
            "data": {
                "num_rows": 13,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Consulted With:"
                    },
                    {
                        "text": "Post/ Approval Committee/ Group:"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Dr Niven Akotia"
                    },
                    {
                        "text": "MEHT Consultant Anaesthetist and HTG Lead"
                    },
                    {
                        "text": "4th February 2019"
                    },
                    {
                        "text": "Dr Shereen Elshazly"
                    },
                    {
                        "text": "MEHT Consultant Haematologist with responsibility for Transfusion"
                    },
                    {
                        "text": "Mr Nick Sheppard"
                    },
                    {
                        "text": "MEHT Blood Bank Manager"
                    },
                    {
                        "text": "Jodie Nightingill"
                    },
                    {
                        "text": "CNS Haematology"
                    },
                    {
                        "text": "Deborah Lepley"
                    },
                    {
                        "text": "Warner Library"
                    },
                    {
                        "text": "21st March 2019"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 5,
            "data": {
                "num_rows": 1,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Related Trust Policies (to be read in conjunction with)"
                    },
                    {
                        "text": "04184 Manual of Blood Transfusion Policies and Procedures 04080 Consent to examination or treatment policy 09100 Incident Policy"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 6,
            "data": {
                "num_rows": 14,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Review History:"
                    },
                    {
                        "text": "Version No:"
                    },
                    {
                        "text": "Authored/Reviewer:"
                    },
                    {
                        "text": "Summary of amendments/ Record documents superseded by:"
                    },
                    {
                        "text": "Issue Date:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Tina Parker Transfusion Nurse"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "3 May 2016"
                    },
                    {
                        "text": "1.1"
                    },
                    {
                        "text": "Tina Parker Transfusion Nurse"
                    },
                    {
                        "text": "Irradiated and specialist component communication document"
                    },
                    {
                        "text": "16th August 2016"
                    },
                    {
                        "text": "1.2"
                    },
                    {
                        "text": "Tina Parker Transfusion"
                    },
                    {
                        "text": "Updated HEV requirement, updated the proforma for pre-assessment, NHSBT new irradiation sticker"
                    },
                    {
                        "text": "23rd October 2018"
                    },
                    {
                        "text": "2.0"
                    },
                    {
                        "text": "Tina Parker"
                    },
                    {
                        "text": "Full Review"
                    },
                    {
                        "text": "3rd April 2019"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 7,
            "data": {
                "is_heading": 1,
                "text": "Index"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 8,
            "data": {
                "is_heading": 1,
                "text": "Appendix 1 Request for Special Requirements - Blood Products Appendix 2 Request to remove Special Requirements"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 9,
            "data": {
                "is_heading": 0,
                "text": "Appendix 3 Pre-Assessment clinic proforma for the pre-assessment of Blood Transfusion Special Requirements"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 10,
            "data": {
                "is_heading": 0,
                "text": "Appendix 4 Poster \u2013 Special Requirements for Blood Transfusion"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 11,
            "data": {
                "is_heading": 0,
                "text": "Appendix 5 East of England Shared Care Document \u2013 Irradiated and"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 12,
            "data": {
                "is_heading": 0,
                "text": "Specialist Blood Components Communications Document"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 13,
            "data": {
                "is_heading": 0,
                "text": "Appendix 6 Preliminary Equality Analysis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 14,
            "data": {
                "is_heading": 0,
                "prefix": 1.1,
                "text": "The Trust is committed to the provision of a service that is fair, accessible and meets the needs of all individuals."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 15,
            "data": {
                "is_heading": 0,
                "prefix": 1.2,
                "text": "The purpose of this document is to ensure that staff are aware of the patients who have special requirements for transfusion, and therefore ensure their requirements are met."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 16,
            "data": {
                "is_heading": 0,
                "prefix": 1.3,
                "text": "To provide information to staff as to which patients may have special requirements."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 17,
            "data": {
                "is_heading": 0,
                "prefix": 1.4,
                "text": "To ensure staff know how to inform the laboratory when patients have special requirements."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 18,
            "data": {
                "is_heading": 0,
                "prefix": 2.1,
                "text": "To ensure patients special transfusion requirements are passed on to laboratory staff in order that the laboratory system is updated to ensure a \u2018flag' and special requirement is placed on the patient's record. This flag will prompt staff so that when any products are issued to that patient they are alerted to the special requirement."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 19,
            "data": {
                "is_heading": 0,
                "prefix": 2.2,
                "text": "By ensuring patients who have special requirements receive them, patient safety can be maintained."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 20,
            "data": {
                "is_heading": 0,
                "prefix": 3.1,
                "text": "This policy covers all patients, adults and children with special blood"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 21,
            "data": {
                "is_heading": 0,
                "text": "transfusion requirements to provide products suitable for their medical"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 22,
            "data": {
                "is_heading": 0,
                "text": "condition, health status or drug treatment. All components, except"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 23,
            "data": {
                "is_heading": 0,
                "text": "granulocytes, are leucodepleted by methods which are demonstrated to leave"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 24,
            "data": {
                "is_heading": 0,
                "prefix": 6.0,
                "text": "a residual WBC of less than 5 x  leucocytes/unit in more than 99 % of units and less than 1 x  leucocytes/unit in more than 90% of units both with 95% statistical confidence."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 25,
            "data": {
                "is_heading": 0,
                "prefix": 3.2,
                "text": "Components that can be provided for patients:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 26,
            "data": {
                "is_heading": 0,
                "text": "Irradiated;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 27,
            "data": {
                "is_heading": 0,
                "text": "IgA deficient;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 28,
            "data": {
                "is_heading": 0,
                "text": "CMV negative;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 29,
            "data": {
                "is_heading": 0,
                "text": "Washed red cells."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 30,
            "data": {
                "is_heading": 0,
                "prefix": 3.3,
                "text": "All UK donations are tested for:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 31,
            "data": {
                "is_heading": 0,
                "text": "ABO, Rh D and K blood group antigens;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 32,
            "data": {
                "is_heading": 0,
                "text": "Atypical red cell antibodies;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 33,
            "data": {
                "is_heading": 0,
                "text": "HBs antigen;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 34,
            "data": {
                "is_heading": 0,
                "text": "antibodies to HIV1&2,HCV, syphilis and HTLV I/II;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 35,
            "data": {
                "is_heading": 0,
                "text": "HCV and HIV genome;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 36,
            "data": {
                "is_heading": 0,
                "text": "HIV/HBV prior to issue;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 37,
            "data": {
                "is_heading": 0,
                "text": "HEV."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 38,
            "data": {
                "is_heading": 0,
                "prefix": 4.1,
                "text": "A blood transfusion special requirement means that an additional process needs to be undertaken by NHSBT on the blood component to make it safe for a specific patient."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 39,
            "data": {
                "is_heading": 0,
                "prefix": 4.2,
                "text": "When a patient has been newly recognised as having special transfusion requirements or potentially requiring these components, it is the responsibility of the Clinician caring for the patient to ensure the laboratory is informed of these requirements."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 40,
            "data": {
                "is_heading": 0,
                "prefix": 4.3,
                "text": "The Special Requirements Request Form (appendix 1) must be completed and sent to the laboratory. The clinician must phone the laboratory when the decision is made, to ensure the \u2018flag' is placed on the patients records in the interim, so that any products issued before the form is received, will be suitable for the patient."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 41,
            "data": {
                "is_heading": 0,
                "prefix": 4.4,
                "text": "When patients are admitted to the hospital and require a transfusion, it is the responsibility of the prescribing/authorising clinician to ensure that they confirm if the patient has any special requirements."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 42,
            "data": {
                "is_heading": 0,
                "prefix": 4.5,
                "text": "The Blood Transfusion request form has a section for special requirements to be documented, but there must also be verbal communication with the laboratory if there is a potential that the patient may have special requirements. It is important not to assume that the laboratory staff know that the patient has this requirement as they may not have been in this hospital since a procedure e.g. Stem Cell Transplant or been given new medication e.g. Fludarabine."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 43,
            "data": {
                "is_heading": 0,
                "prefix": 4.6,
                "text": "If a patient is being treated at another Trust and may be admitted to MEHT it is the responsibility of the clinical team caring for the patient, to ensure that the shared care documentation is sent to the laboratory so that confirmation of which special transfusion requirement is needed is documented in the patients laboratory records."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 44,
            "data": {
                "is_heading": 0,
                "prefix": 4.7,
                "text": "When a verbal request for a special requirement is received, laboratory staff will temporarily place a \u2018flag' on the patient's record. This will ensure that the warning is present immediately, so that in the event the patient requires blood components this warning is present for the staff issuing blood."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 45,
            "data": {
                "is_heading": 0,
                "prefix": 4.8,
                "text": "Once the written request has been received, senior laboratory staff will update the patients' laboratory records. This special requirement warning will remain on the patient's records until a removal of special requirement request form is received. (Refer to appendix 2)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 46,
            "data": {
                "is_heading": 0,
                "prefix": 4.9,
                "text": "Laboratory staff can be informed in a variety of ways; however the Doctor caring for the patient takes overall responsibility for ensuring laboratory staff are informed of the special requirement."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 47,
            "data": {
                "is_heading": 0,
                "prefix": 5.1,
                "text": "Graft versus Host Disease: This rare and almost always fatal complication"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 48,
            "data": {
                "is_heading": 0,
                "text": "occurs when viable lymphocytes in a blood donation engraft in the patient and mount an immune response against the recipient's cells of a different HLA"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 49,
            "data": {
                "is_heading": 0,
                "text": "type. At-risk patients usually have impaired cell-mediated immunity and are"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 50,
            "data": {
                "is_heading": 0,
                "text": "unable to reject the foreign cells. 5.1.1 At Risk Populations are:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 51,
            "data": {
                "is_heading": 0,
                "text": "Patients receiving transfusions from a first degree relative (parent, child or sibling) or second degree relative (grandparent, grandchild, uncle, aunt, nephew, niece or half sibling)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 52,
            "data": {
                "is_heading": 0,
                "prefix": 5.2,
                "text": "Patients receiving a granulocyte transfusion."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 53,
            "data": {
                "is_heading": 0,
                "prefix": 5.3,
                "text": "Patients receiving Human Leucocyte Antigen (HLA) \u2013 selected components."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 54,
            "data": {
                "is_heading": 0,
                "prefix": 5.4,
                "text": "Patients receiving or who have received purine analogues (e.g. fludarabine,"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 55,
            "data": {
                "is_heading": 0,
                "text": "cladrabine, deoxycoformicin, bendamustine), for life. For newer purine"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 56,
            "data": {
                "is_heading": 0,
                "text": "analogues and related drugs, irradiated components should be given until"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 57,
            "data": {
                "is_heading": 0,
                "text": "further data are available. This is not an exhaustive list and can be updated at any time."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 58,
            "data": {
                "is_heading": 0,
                "prefix": 5.5,
                "text": "All intrauterine transfusions (IUT). Other neonates receiving red cell or platelet transfusions \u2013 where there has been a previous IUT (irradiated components"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 59,
            "data": {
                "is_heading": 0,
                "text": "should be given until six months after the expected delivery date) or if the"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 60,
            "data": {
                "is_heading": 0,
                "text": "donation is from a first or second degree relative."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 61,
            "data": {
                "is_heading": 0,
                "prefix": 5.6,
                "text": "Neonatal exchange transfusions (ET) if there has been a previous IUT or if the donation comes from a first or second degree relative. For other neonatal"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 62,
            "data": {
                "is_heading": 0,
                "text": "exchange transfusions, irradiation is recommended providing that irradiation"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 63,
            "data": {
                "is_heading": 0,
                "text": "does not unduly delay transfusion."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 64,
            "data": {
                "is_heading": 0,
                "prefix": 5.7,
                "text": "Patients with Hodgkin Lymphoma, at any stage of the disease (for life)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 65,
            "data": {
                "is_heading": 0,
                "prefix": 5.8,
                "text": "Patients receiving allogeneic haemopoietic stem cell (HSC) grafts, from the"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 66,
            "data": {
                "is_heading": 0,
                "text": "start of conditioning therapy and while the patient remains on Graft-versus-"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 67,
            "data": {
                "is_heading": 0,
                "text": "Host Disease(GvHD) prophylaxis (usually six month post-transplant). If chronic GvHD is present or the patient is taking immuno-suppressants, continue"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 68,
            "data": {
                "is_heading": 0,
                "text": "irradiated blood components indefinitely."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 69,
            "data": {
                "is_heading": 0,
                "prefix": 5.9,
                "text": "Allogeneic HSC donors being transfused seven days prior to or during the Harvest of their HSC."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 70,
            "data": {
                "is_heading": 0,
                "prefix": 5.1,
                "text": "Patients who have autologous HSC graft:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 71,
            "data": {
                "is_heading": 0,
                "text": "Any transfusion seven days prior to and during the one marrow-stem cell harvest;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 72,
            "data": {
                "is_heading": 0,
                "text": "Any transfusion from the start of conditioning chemo-radiotherapy until three months post-transplant (six months if total body irradiation was used)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 73,
            "data": {
                "is_heading": 0,
                "prefix": 5.11,
                "text": "Patients with aplastic anaemia receiving immuno suppressive therapy with anti- thymocyte globulin (ATG) and/or alemtuzumab (anti-CD52)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 74,
            "data": {
                "is_heading": 0,
                "prefix": 5.12,
                "text": "Patients with known or suspected T-cell immunodeficiency, such as Di-George syndrome, the blood should be transfused within 24 hours of irradiation."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 75,
            "data": {
                "is_heading": 0,
                "prefix": 5.13,
                "text": "Patients receiving alemtuzumab for solid organ transplantation."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 76,
            "data": {
                "is_heading": 0,
                "prefix": 5.14,
                "text": "If patients are on a drug trial, clinical staff need to check what the drug regime for those Trials includes, to determine if irradiated components are required."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 77,
            "data": {
                "is_heading": 0,
                "prefix": 5.15,
                "text": "It is not necessary to irradiate Fresh Frozen Plasma, Cryoprecipitate or fractionated plasma products."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 78,
            "data": {
                "is_heading": 0,
                "prefix": 5.16,
                "text": "When the decision is made that the patient needs irradiated components, inform the patient, provide the NHSBT leaflet \u201cInformation for patients needing irradiated blood\u201d. This leaflet contains a card for the patient to carry stating they are at risk of transfusion-associated graft-versus-host disease."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 79,
            "data": {
                "is_heading": 0,
                "prefix": 5.17,
                "text": "Place the sticker from the leaflet inside the front page of the patient's notes. This will alert staff when a patient is admitted that they require irradiated components."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 80,
            "data": {
                "is_heading": 0,
                "prefix": 5.18,
                "text": "When transfusing a patient with the requirement for irradiated blood products check the pack for the RadTag irradiation indicator label. A blue dot indicates that the component is irradiated if the dot is white it is not irradiated."
            }
        },
        {
            "type": "image",
            "sequence_num": 81,
            "data": {
                "url": "16015 Special Requirements Blood Transfusion 2.0.003.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 82,
            "data": {
                "is_heading": 0,
                "prefix": 6.1,
                "text": "Cytomegalovirus is a common herpes virus that causes asymptomatic"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 83,
            "data": {
                "is_heading": 0,
                "text": "infection or a mild glandular fever-like illness in most healthy individuals."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 84,
            "data": {
                "is_heading": 0,
                "text": "Despite an antibody response (seroconversion), the virus persists in blood monocytes and 50\u201360% of adults in the UK, including blood donors, are lifelong carriers of the virus. It can be transmitted by transfusion of cellular blood components although this may be difficult to distinguish from"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 85,
            "data": {
                "is_heading": 0,
                "text": "reactivation of previous infection. CMV can cause severe, sometimes fatal, infection in foetuses, neonates and immunocompromised adults."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 86,
            "data": {
                "is_heading": 0,
                "prefix": 6.2,
                "text": "CMV seronegative red cells and platelets should be provided for intrauterine transfusions, neonates (up to 28 days after expected date of delivery) or if the patient has had an IUT."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 87,
            "data": {
                "is_heading": 0,
                "prefix": 6.3,
                "text": "CMV seronegative granulocytes should be provided for CMV seronegative recipients."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 88,
            "data": {
                "is_heading": 0,
                "prefix": 6.4,
                "text": "CMV seronegative red cells and platelets should be provided, where possible, for pregnant women. In an emergency, such as major haemorrhage, standard leucocytedepleted components should be given to avoid delay."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 89,
            "data": {
                "is_heading": 0,
                "prefix": 6.5,
                "text": "Standard pre-storage leucodepleted components are suitable for all other"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 90,
            "data": {
                "is_heading": 0,
                "text": "transfusion recipients, including haemopoietic stem cell transplant patients,"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 91,
            "data": {
                "is_heading": 0,
                "text": "organ transplant patients and immune deficient patients, including those with HIV."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 92,
            "data": {
                "is_heading": 0,
                "prefix": 6.6,
                "text": "When transfusing a patient who has the CMV negative requirement, ensure the pack states this requirement on it."
            }
        },
        {
            "type": "image",
            "sequence_num": 93,
            "data": {
                "url": "16015 Special Requirements Blood Transfusion 2.0.004.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 94,
            "data": {
                "is_heading": 0,
                "prefix": 7.1,
                "text": "Indicated for patients with recurrent or severe allergic or febrile reactions to"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 95,
            "data": {
                "is_heading": 0,
                "text": "red cells, and severely IgA-deficient patients with anti-IgA antibodies for whom red cells from an IgA deficient donor are not available."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 96,
            "data": {
                "is_heading": 0,
                "prefix": 7.2,
                "text": "The decision to provide a specific patient with washed red cells must be made by a Consultant Haematologist. Refer any patients with recurrent or severe"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 97,
            "data": {
                "is_heading": 0,
                "text": "allergic reactions to the Consultant Haematologist for advice."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 98,
            "data": {
                "is_heading": 0,
                "prefix": 7.3,
                "text": "Washed red cells can be used for IgA deficient patients with anti-IgA antibodies if red cells from IgA deficient donors are not available."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 99,
            "data": {
                "is_heading": 0,
                "prefix": 7.4,
                "text": "The shelf life for both irradiated and non- irradiated automated washed cells is set at 14 days post washing and irradiation. However, production of these, in extenuating circumstances, may be manual with suspension in saline not"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 100,
            "data": {
                "is_heading": 0,
                "prefix": 24.0,
                "text": "SAGM. This will result in a  hour shelf life component."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 101,
            "data": {
                "is_heading": 0,
                "prefix": 8.1,
                "text": "Whilst not specifically a \u2018special requirement', it is important to determine if"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 102,
            "data": {
                "is_heading": 0,
                "text": "there are any present. Patients known to have red cell antibodies will require blood which is specifically selected for them. When a group and save or cross match request is received in the laboratory it is processed via an analyser. If there are no red cell antibodies present, and the patient has not had a"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 103,
            "data": {
                "is_heading": 0,
                "text": "transfusion or been pregnant since the sample was taken, then blood can be issued."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 104,
            "data": {
                "is_heading": 0,
                "prefix": 8.2,
                "text": "If a red cell antibody is found on analysing, then it is dependent on which"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 105,
            "data": {
                "is_heading": 0,
                "text": "antibody the patient has, as to whether blood components can be issued at MEHT."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 106,
            "data": {
                "is_heading": 0,
                "prefix": 8.3,
                "text": "If the patient has a red cell antibody that cannot be cross matched on site, then samples will be sent to Colindale for cross matching. This can cause a delay in blood being available for the patient. However, in an emergency the most suitable unit available at MEHT would be issued for the patient."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 107,
            "data": {
                "is_heading": 0,
                "prefix": 9.1,
                "text": "These can be selected from platelets in stock or donors may be asked to"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 108,
            "data": {
                "is_heading": 0,
                "text": "donate platelets for an individual case following discussion with a H&I"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 109,
            "data": {
                "is_heading": 0,
                "text": "consultant in NHSBT. HPA platelets are stocked in Filton, Tooting, Sheffield and Manchester. 24 hours' notice is required where possible."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 110,
            "data": {
                "is_heading": 0,
                "prefix": 9.2,
                "text": "For prophylaxis or treatment of bleeding in thrombocytopenic patients who are refractory to random platelets due to HLA or HPA alloimmunisation."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 111,
            "data": {
                "is_heading": 1,
                "prefix": 10.0,
                "text": "Autologous Blood"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 112,
            "data": {
                "is_heading": 0,
                "prefix": 10.1,
                "text": "The collection of autologous blood prior to elective surgery should only be considered in exceptional circumstances, e.g. patients with rare red cell antibodies. Any requests should be discussed with a MEHT Consultant"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 113,
            "data": {
                "is_heading": 0,
                "text": "Haematologist and NHSBT Consultant."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 114,
            "data": {
                "is_heading": 0,
                "text": "Special Requirements For Blood Transfusion / 16015 / 2.0"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 115,
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": ""
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 116,
            "data": {
                "is_heading": 0,
                "prefix": 11.1,
                "text": "Once the decision that the patient no longer has a \u2018special requirement' is made, it is the responsibility of the Consultant caring for the patient, to ensure the laboratory is informed."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 117,
            "data": {
                "is_heading": 0,
                "prefix": 11.2,
                "text": "Complete the \u2018Request for the Removal of Special Requirements - Blood"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 118,
            "data": {
                "is_heading": 0,
                "text": "Products' form (refer to appendix 2) and ensure this is sent to the laboratory."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 119,
            "data": {
                "is_heading": 0,
                "prefix": 12.1,
                "text": "If patients have special transfusion requirements, and receive a blood component that did not meet that need, this puts the patient at risk. The outcome could be anything from a mild transfusion reaction, to blindness of a foetus, or death from Transfusion Associated Graft versus Host Disease (TAGvHD) in the case of patients needing irradiated components."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 120,
            "data": {
                "is_heading": 0,
                "prefix": 12.2,
                "text": "Completing the information on the special requirements form, and ensuring that laboratory staff are informed as soon as possible, will reduce risks of incidents occurring."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 121,
            "data": {
                "is_heading": 0,
                "prefix": 12.3,
                "text": "If a patient receives a component that did not meet their specific needs this needs to be reported to the clinician caring for the patient, and the Consultant Haematologist (if this is not the same person) as soon as possible."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 122,
            "data": {
                "is_heading": 0,
                "prefix": 12.4,
                "text": "The Consultant Haematologist will need to review the patient, and determine the consequences of the patient receiving this product."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 123,
            "data": {
                "is_heading": 0,
                "prefix": 12.5,
                "text": "The patient and/or family will need to be informed of the incident by the responsible Consultant."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 124,
            "data": {
                "is_heading": 0,
                "prefix": 12.6,
                "text": "Complete a Datixweb incident, documenting the incident details. Ensure the laboratory staff are informed of the incident."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 125,
            "data": {
                "is_heading": 0,
                "prefix": 12.7,
                "text": "If the event is due to a laboratory staff error, this will be escalated to the Executive Review Group (ERG) for review, and reported to the CCG as appropriate."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 126,
            "data": {
                "is_heading": 0,
                "prefix": 12.8,
                "text": "If the event reported is due to the Doctor caring for the patient (e.g. not informing the laboratory correctly of the special requirement), then this needs to be escalated by the clinical team caring for the patient to the Trust's Incident review team."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 127,
            "data": {
                "is_heading": 0,
                "prefix": 12.9,
                "text": "Incidents of SPRNM \u2013 \u2018Special Requirements Not Met', are also SHOT reportable:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 128,
            "data": {
                "is_heading": 0,
                "text": "Serious Hazards of Transfusion. If the error originated from the laboratory then it is also SABRE reportable (the Serious Blood Reactions and Events body). Ensure the  Blood Transfusion Department is informed so that the"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 129,
            "data": {
                "is_heading": 0,
                "text": "correct person is notified so they can report incidents to these external organisations."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 130,
            "data": {
                "is_heading": 1,
                "prefix": 13.0,
                "text": "Audit and Monitoring"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 131,
            "data": {
                "is_heading": 0,
                "prefix": 13.1,
                "text": "The Blood Transfusion Department will take part in all appropriate NHSBT audits to monitor and assess the trusts performance nationally against the procedures in the transfusion policy. Findings from all National Audits organised by the NHSBT will be reported to the HTT and HTG meetings."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 132,
            "data": {
                "is_heading": 0,
                "prefix": 13.2,
                "text": "Annual audits of compliance of the transfusion request forms against the Special Requirement for Blood Transfusion policy will be undertaken by the Blood Bank manager."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 133,
            "data": {
                "is_heading": 0,
                "prefix": 13.3,
                "text": "The findings will be reported to the HTG and this group will monitor implementation of any organisational actions developed to address any deficiencies. The Chair of the HTG will be responsible for ensuring actions are progressed."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 134,
            "data": {
                "is_heading": 0,
                "prefix": 13.4,
                "text": "Audit findings will also be reported to appropriate divisional / directorate governance meetings and clinical leads will be responsible for developing local actions to address any non-compliance."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 135,
            "data": {
                "is_heading": 1,
                "prefix": 14.0,
                "text": "Equality Impact Assessment"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 136,
            "data": {
                "is_heading": 0,
                "prefix": 14.1,
                "text": "Mid Essex Hospital Services NHS Trust is committed to the provision of a service that is fair, accessible and meets the needs of all individuals. (Refer to Appendix 6)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 137,
            "data": {
                "is_heading": 1,
                "prefix": 14.0,
                "text": "References"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 138,
            "data": {
                "is_heading": 0,
                "text": "5th Norfolk, D (2013) Handbook of Transfusion Medicine. 5th edition. Norwich: TSO http://www.transfusionguidelines.org.uk/transfusion-handbook"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 139,
            "data": {
                "is_heading": 0,
                "text": "Walters, G (2016) NHSBT Specification SPN223/8 NHSBT Portfolio of Blood Components and"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 140,
            "data": {
                "is_heading": 0,
                "text": "Guidance for their Clinical Use. Bristol: NHSBT https://nhsbtdbe.blob.core.windows.net/umbraco-assets hosp/1447/spn223.pdf -"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 141,
            "data": {
                "is_heading": 0,
                "text": "NHSBT (2018) FACTSHEET Cytomegalovirus (CMV) Negative Blood Components"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 142,
            "data": {
                "is_heading": 0,
                "text": "Information for Healthcare Professionals https://nhsbtdbe.blob.core.windows.net/umbraco-assets-  corp/14652/blc7071.pdf"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 143,
            "data": {
                "is_heading": 0,
                "text": "SHOT / MHRA (2017) UK Haemovigilance: user guide for mandatory"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 144,
            "data": {
                "is_heading": 0,
                "text": "and professionally mandated haemovigilance reporting in the UK www.shotuk.org/wp-content/uploads/myimages/Joint-UK-Haemovigilance- user_guide-2017.pdf"
            }
        },
        {
            "type": "image",
            "sequence_num": 145,
            "data": {
                "url": "16015 Special Requirements Blood Transfusion 2.0.005.jpeg"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 146,
            "data": {
                "is_heading": 1,
                "text": "* Who needs to receive irradiated blood components?"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 147,
            "data": {
                "is_heading": 0,
                "text": "Patients receiving transfusions from a first degree relative (parent, child or sibling) or second degree relative (grandparent, grandchild, uncle, aunt, nephew, niece or half sibling)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 148,
            "data": {
                "is_heading": 0,
                "text": "Patients receiving a granulocyte transfusion."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 149,
            "data": {
                "is_heading": 0,
                "text": "Patients receiving Human Leucocyte Antigen (HLA) \u2013 selected components."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 150,
            "data": {
                "is_heading": 0,
                "text": "Patients receiving purine analogues (e.g. fludarabine, cladrabine, deoxycoformicin): for life. For newer purine analogues and related drugs, such as bendamustine, irradiated components should be given until further data are available."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 151,
            "data": {
                "is_heading": 0,
                "text": "All intrauterine transfusions (IUT). Other neonates receiving red cell or platelet transfusions \u2013 where there has been a previous IUT (irradiated components should be given until six months after the expected delivery date) or if the donation is from a first or second degree relative."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 152,
            "data": {
                "is_heading": 0,
                "text": "Neonatal exchange transfusions (ET) if there has been a previous IUT or if the donation comes from a first or second degree relative. For other neonatal ET, irradiation is recommended providing that irradiation does not unduly delay transfusion."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 153,
            "data": {
                "is_heading": 0,
                "text": "Patients with Hodgkin Lymphoma, at any stage of the disease (for life)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 154,
            "data": {
                "is_heading": 0,
                "text": "Patients receiving allogeneic haemopoietic stem cell (HSC) grafts, from the start of conditioning therapy and while the patient remains on Graft-versus-Host Disease (GvHD) prophylaxis (usually six month post-transplant). If chronic GvHD is present or the patient is taking immunosuppressant's, continue irradiated blood components indefinitely."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 155,
            "data": {
                "is_heading": 0,
                "text": "Allogeneic HSC donors being transfused seven days prior to or during the harvest of their HSC."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 156,
            "data": {
                "is_heading": 0,
                "text": "Patients who have autologous HSC graft:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 157,
            "data": {
                "is_heading": 0,
                "text": "Patients with aplastic anaemia receiving immuno suppressive therapy with anti-thymocyte globulin (ATG) and/or alemtuzumab (anti-CD52)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 158,
            "data": {
                "is_heading": 0,
                "text": "Patients with known or suspected T-cell immunodeficiency, such as Di-George syndrome, the blood should be transfused within 24 hours of irradiation."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 159,
            "data": {
                "is_heading": 0,
                "text": "Patients receiving alemtuzumab for solid organ transplantation."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 160,
            "data": {
                "is_heading": 1,
                "text": "Who should you inform if you patient requires irradiated blood components?"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 161,
            "data": {
                "is_heading": 0,
                "text": "In order to prevent the risk of TA-GvHD, please inform the transfusion laboratory, the shared care hospital (if appropriate), nursing staff and most importantly of all, the patient of the need for irradiated blood components. A patient information leaflet \u2018Information for patients needing irradiated blood' is available from the blood transfusion department."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 162,
            "data": {
                "is_heading": 1,
                "text": "Why is it important these patients receive irradiated blood components?"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 163,
            "data": {
                "is_heading": 0,
                "text": "Irradiating blood components prevents the donor white cells replicating and mounting an immune response against a vulnerable patient causing transfusion-associated graft-versus-host disease (TA-GvHD)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 164,
            "data": {
                "is_heading": 1,
                "text": "Which components need to be irradiated?"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 165,
            "data": {
                "is_heading": 0,
                "text": "Only cellular blood components (red cells, platelets and granulocytes) need to be irradiated."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 166,
            "data": {
                "is_heading": 0,
                "text": "Fresh Frozen Plasma (FFP), cryoprecipitate, frozen washed red cells and fractionated plasma products do not need to be irradiated as the lymphocytes will not, or are extremely unlikely to, survive the freezing/washing/fractionation process."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 167,
            "data": {
                "is_heading": 0,
                "text": "*For further information see current version of \u201cIrradiated Blood Components Information for Healthcare Professionals Factsheet\u201d"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 168,
            "data": {
                "is_heading": 1,
                "text": "Appendix 3 Pre-Assessment clinic proforma for the pre-assessment of Blood Transfusion Special Requirements"
            }
        },
        {
            "type": "image",
            "sequence_num": 169,
            "data": {
                "url": "16015 Special Requirements Blood Transfusion 2.0.006.jpeg"
            }
        },
        {
            "type": "image",
            "sequence_num": 170,
            "data": {
                "url": "16015 Special Requirements Blood Transfusion 2.0.007.jpeg"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 171,
            "data": {
                "is_heading": 1,
                "text": "Appendix 4 Poster \u2013 Special Requirements for Blood Transfusion"
            }
        },
        {
            "type": "image",
            "sequence_num": 172,
            "data": {
                "url": "16015 Special Requirements Blood Transfusion 2.0.008.jpeg"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 173,
            "data": {
                "is_heading": 0,
                "text": "Special Requirements For Blood Transfusion / 16015 / 2.0"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 174,
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": ""
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 175,
            "data": {
                "is_heading": 0,
                "text": "Appendix 5 Shared Care Document"
            }
        },
        {
            "type": "image",
            "sequence_num": 176,
            "data": {
                "url": "16015 Special Requirements Blood Transfusion 2.0.009.jpeg"
            }
        },
        {
            "type": "image",
            "sequence_num": 177,
            "data": {
                "url": "16015 Special Requirements Blood Transfusion 2.0.010.jpeg"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 178,
            "data": {
                "is_heading": 1,
                "text": "Appendix 6: Preliminary Equality Analysis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 179,
            "data": {
                "is_heading": 1,
                "text": "This assessment relates to: (please tick all that apply)"
            }
        },
        {
            "type": "table",
            "sequence_num": 180,
            "data": {
                "num_rows": 9,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "A change in a service to patients"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "A change to an existing policy"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "A change to the way staff work"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "A new policy"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Something else (please give details)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Questions"
                    },
                    {
                        "text": "Answers"
                    },
                    {
                        "text": "What are you proposing to change?"
                    },
                    {
                        "text": "Full Review"
                    },
                    {
                        "text": "Why are you making this change? (What will the change achieve?)"
                    },
                    {
                        "text": "3 year review"
                    },
                    {
                        "text": "Who benefits from this change and how?"
                    },
                    {
                        "text": "Patients and clinicians"
                    },
                    {
                        "text": "Is anyone likely to suffer any negative impact as a result of this change? If no, please record reasons here and sign and date this assessment. If yes, please complete a full EIA."
                    },
                    {
                        "text": "No"
                    },
                    {
                        "text": "a) Will you be undertaking any consultation as part of this change? b) If so, with whom?"
                    },
                    {
                        "text": "Refer to pages 1 and 2"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 181,
            "data": {
                "is_heading": 1,
                "text": "Preliminary analysis completed by:"
            }
        },
        {
            "type": "table",
            "sequence_num": 182,
            "data": {
                "num_rows": 1,
                "num_cols": 6,
                "table_items": [
                    {
                        "text": "Name"
                    },
                    {
                        "text": "Tina Parker"
                    },
                    {
                        "text": "Job Title"
                    },
                    {
                        "text": "Transfusion Nurse"
                    },
                    {
                        "text": "Date"
                    },
                    {
                        "text": "February 2019"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 183,
            "data": {
                "is_heading": 0,
                "text": "Special Requirements For Blood Transfusion / 16015 / 2.0"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 184,
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": ""
            }
        }
    ]
}